340
Participants
Start Date
September 30, 2016
Primary Completion Date
January 15, 2022
Study Completion Date
January 15, 2022
oXiris®
"oXiris® membrane set is composed of a 1.5 m2 copolymer of acrylonitrile and sodium methylsulfonate (AN 69) with polyethylenimine treated surface and adhered heparin during set´s fabrication \[oXiris® (Baxter Gambro)\].~Blood flow between 200-250 mL/min will be derivatised from the CPB circuit (arterial positive pressure line just after the oxygenator) into the PrismafleX eXeed™, so that it all flows thru the oXiris® membrane and returned to the CPB circuit into the venous reservoir just before the oxygenator. oXiris® membrane will be only employed for adsorption (neither convection nor diffusion will be performed) during all CPB time."
Hospital German Trias i Pujol, Badalona
Hospital de la Santa Creu i Sant Pau, Barcelona
Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat
Hospital Germans TrÃ-es i Pujol de Badalona
UNKNOWN
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
UNKNOWN
Baxter Healthcare Corporation
INDUSTRY
Instituto de Salud Carlos III
OTHER_GOV
Hospital Universitari de Bellvitge
OTHER